Institutional Ownership
Cytek Biosciences Inc
CUSIP 23285D109COMCTKBQ1 2026
13D / 13G Filings
30
Schedule 13D/13G on record
Beneficial Filers
14
Distinct reporting persons
Largest Stake
14.3%
Max % of class reported
Institutional Holders
161
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
30 filings · latest Nov 17, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 17, 2025 | Topline Capital Management, LLC | 13G | 5.3% | 6.78M | SEC |
| 2 | Nov 12, 2025 | Brown Capital Management, LLC | 13G/A | 3.9% | 4.96M | SEC |
| 3 | Jul 29, 2025 | The Vanguard Group | 13G/A | 6.1% | 7.77M | SEC |
| 4 | Jul 18, 2025 | Blackrock, Inc. | 13G/A | 13.1% | 16.53M | SEC |
| 5 | May 15, 2025 | Brown Capital Management, LLC | 13G/A | 5.9% | 7.46M | SEC |
| 6 | Apr 30, 2025 | The Vanguard Group | 13G/A | 7.5% | 9.62M | SEC |
| 7 | Feb 14, 2025 | Ra Capital Management, L.P. | 13G/A | — | 913.31M | SEC |
| 8 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 14.3% | 18.48M | SEC |
| 9 | Nov 14, 2024 | Brown Capital Management LLC | 13G/A | 7.2% | 9.49M | SEC |
| 10 | Nov 14, 2024 | Hillhouse Investment Management, Ltd. | 13G | 5.1% | 6.66M | SEC |
20 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Cytek Biosciences Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 17.01M | $74.32M |
| 2 | Topline Capital Management, LLC | 7.06M | $30.87M |
| 3 | Hhlr Advisors, Ltd. | 6.66M | $29.09M |
| 4 | Millennium Management LLC | 6.29M | $27.50M |
| 5 | Boston Partners | 5.80M | $25.36M |
| 6 | State Street Corp | 4.12M | $18.02M |
| 7 | Geode Capital Management, LLC | 2.83M | $12.39M |
| 8 | Dimensional Fund Advisors LP | 2.66M | $11.64M |
| 9 | Goldman Sachs Group Inc | 2.34M | $10.25M |
| 10 | Morgan Stanley | 1.72M | $7.51M |